StockData

Microchip Technology vs Skyworks Solutions

MCHP and SWKS side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MCHP and SWKS compare

Microchip Technology is the larger company, worth 3.2 times as much as Skyworks Solutions ($42.0B against $13.2B).

On earnings, Skyworks Solutions is cheaper: it trades at 45.4× trailing earnings, against 115× for Microchip Technology.

Microchip Technology grew revenue faster over the last twelve months (20.9% versus 0.06% for Skyworks Solutions).

Microchip Technology keeps more of each dollar of sales as profit, with a net margin of 9.3% compared with 7.2% at Skyworks Solutions.

Both pay dividends: Microchip Technology yields 2.4% and Skyworks Solutions 2.4%.

Microchip Technology scores higher on the StockData Score (12 against 11 for Skyworks Solutions), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMCHPSWKS
Size and price
Market cap$42.0B$13.2B
Share price$77.34$87.58
Change, 1 year23.7%11.2%
Change, 5 years−9.8%−46.6%
Beta (5Y)1.671.31
Employees18K10K
StockData Score
Total score12 (better)11
Valuation score01 (better)
Growth score3 (better)0
Performance score22
Health score46 (better)
Dividend score3 (better)2
Valuation
P/E115×45.4× (better)
P/S8.2×3.3× (better)
P/B6.5×2.3× (better)
EV/EBITDA32.0× (better)40.5×
P/FCF37.8×30.4× (better)
FCF yield2.6%3.3% (better)
Fair value$33.00$60.75
Margin of safety−134%−44.2% (better)
Growth
Revenue growth (TTM)20.9% (better)0.06%
Revenue growth, 5Y average−2.8%4.0% (better)
Net income growth (TTM)–−26.8%
EPS growth (TTM)–−22.8%
EPS growth, 5Y average−19.5%−8.5% (better)
Profitability
Gross margin60.2% (better)40.7%
Operating margin15.5% (better)7.6%
Net margin9.3% (better)7.2%
FCF margin21.7% (better)10.8%
Return on equity7.2% (better)5.1%
Return on invested capital5.6% (better)5.6%
Financial health
Debt / equity0.83 (better)0.00
Net debt / EBITDA3.46 (better)−2.62
Interest coverage3.7×11.5× (better)
Current ratio1.923.10 (better)
Altman Z-score4.286.70 (better)
Piotroski F-score6 (better)5
Dividends and buybacks
Dividend yield2.4%2.4% (better)
Payout ratio206%147%
Years of dividend growth17 (better)12
Dividend growth, 5Y average19.5% (better)9.1%
Buyback yield−0.15%–
Shareholder yield2.2%2.4% (better)
Ownership
Held by institutions100%122%
Held by insiders2.0%0.49%
Insider net buying, 12 months−$71.1M−$765K (better)
Superinvestors holding2–
Short interest, % of float–18.6%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.